Item 7.01 Regulation FD Disclosure.

Cyclacel Pharmaceuticals, Inc. (the "Company") is aware that the Federal Deposit Insurance Corporation has taken control of Silicon Valley Bank ("SVB") due to liquidity concerns. The Company does not hold any deposits at SVB or have any other direct investments at SVB.

The information contained in this Item 7.01 is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section. The information in this Item 7.01 shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

© Edgar Online, source Glimpses